Baird Medical Investment Holdings Limited
$1.79
▲
2.63%
2026-04-21 05:36:01
bairdmed.com
NCM: BDMD
Explore Baird Medical Investment Holdings Limited stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$64.64 M
Current Price
$1.79
52W High / Low
$7.26 / $0.76
Stock P/E
55.75
Book Value
$1.34
Dividend Yield
—
ROCE
35.34%
ROE
-8.03%
Face Value
—
EPS
$-0.11
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
143
Beta
-1.16
Debt / Equity
63.33
Current Ratio
1.71
Quick Ratio
1.74
Forward P/E
—
Price / Sales
2.04
Enterprise Value
$67.09 M
EV / EBITDA
72.97
EV / Revenue
2.11
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | iRhythm Holdings, Inc. | $124.91 | — | $4.04 B | — | -5.75% | -36.57% | $212 / $97.16 | $4.73 |
| 2. | Hyperfine, Inc. | $1.29 | — | $128.32 M | — | -85.19% | -79.01% | $2.22 / $0.53 | $0.42 |
| 3. | Haemonetics Corporation | $61.17 | 16.14 | $2.83 B | — | 10.74% | 19.3% | $87.32 / $47.31 | $19.46 |
| 4. | Neuronetics, Inc. | $1.58 | — | $109.46 M | — | -28.31% | -1.35% | $4.85 / $0.8 | $0.32 |
| 5. | Pulsenmore Ltd. | $3.33 | — | $72.38 M | — | -33.09% | -17.62% | $1,468 / $1,000 | — |
| 6. | Tactile Systems Technology, Inc. | $25.52 | 30.42 | $580.59 M | — | 12.57% | 8.77% | $37.77 / $8.61 | $9.76 |
| 7. | Pacific Biosciences of California, Inc. | $1.74 | — | $510.38 M | — | -78.39% | -2.13% | $2.73 / $0.85 | $0.02 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 37.04 M | 31.46 M | 35.09 M | 27.72 M |
| Operating Profit | 15.32 M | 12.65 M | 15.01 M | 13.09 M |
| Net Profit | 12.45 M | 10.55 M | 12.57 M | 10.09 M |
| EPS in Rs | 0.34 | 0.29 | 0.34 | 0.27 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 77.96 M | 56.71 M | 42.62 M | 25.28 M |
| Total Liabilities | 38.2 M | 21 M | 16.84 M | 10.26 M |
| Equity | 39.66 M | 35.75 M | 25.93 M | 15.38 M |
| Current Assets | 61.42 M | 40.08 M | 33.76 M | 21.45 M |
| Current Liabilities | 34.62 M | 18.98 M | 16.02 M | 9.77 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -6.31 M | -1.02 M | 0.49 M | 5.26 M |
| Investing CF | -2.85 M | -2.64 M | -5.92 M | -1.39 M |
| Financing CF | 10.72 M | 3.46 M | 4.41 M | -1.93 M |
| Free CF | -9.17 M | -3.66 M | -5.47 M | 3.87 M |
| Capex | -2.85 M | -2.64 M | -5.95 M | -1.39 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 17.74% | -10.35% | 26.58% | — |
| Earnings Growth % | 18.09% | -16.09% | 24.58% | — |
| Profit Margin % | 33.62% | 33.52% | 35.82% | 36.39% |
| Operating Margin % | 41.35% | 40.22% | 42.77% | 47.23% |
| Gross Margin % | 88.16% | 86.56% | 79.9% | 83.61% |
| EBITDA Margin % | 43.66% | 44.59% | 46.43% | 51.08% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.